Practices, patients and (im)perfect data - feasibility of a randomised controlled clinical drug trial in German general practices

Trials

Volumn 12, Issue , 2011, Pages

  Gágyor, Ildikó ^a   Bleidorn, Jutta ^b   Wegscheider, Karl ^c   Hummers Pradier, Eva ^b   Kochen, Michael M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; IBUPROFEN; ANTIINFECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; DIARRHEA; DOUBLE BLIND PROCEDURE; FEASIBILITY STUDY; FEMALE; GENERAL PRACTICE; GERMANY; GOOD CLINICAL PRACTICE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL STAFF; MULTICENTER STUDY; NAUSEA; NURSE; PATIENT SAFETY; PATIENT SELECTION; PRIMARY HEALTH CARE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEAFNESS; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE; VOMITING; ADOLESCENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOPERATION; HEALTH PERSONNEL ATTITUDE; INTERDISCIPLINARY COMMUNICATION; MIDDLE AGED; PHARMACOKINETICS; RISK ASSESSMENT; SAMPLE SIZE; TREATMENT OUTCOME; WORKLOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATTITUDE OF HEALTH PERSONNEL; CIPROFLOXACIN; COOPERATIVE BEHAVIOR; DOUBLE-BLIND METHOD; FEASIBILITY STUDIES; FEMALE; GENERAL PRACTICE; GERMANY; HUMANS; IBUPROFEN; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; PATIENT SELECTION; RISK ASSESSMENT; SAMPLE SIZE; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; WORKLOAD; YOUNG ADULT;

EID: 79953250582     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-91     Document Type: Article

References (26)

1. Rose PW, Harnden A, Brueggemann AB, Perera R, Sheikh A, Crook D, et al. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet 2005, 366:37-43. 10.1016/S0140-6736(05)66709-8, 15993231.
2. Everitt HA, Little PS, Smith PW. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ 2006, 333:321. 10.1136/bmj.38891.551088.7C, 1539078, 16847013.
3. Delaney BC, Qume M, Moayyedi P, Logan RF, Ford AC, Elliott C, et al. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). BMJ 2008, 336:651-654. 10.1136/bmj.39479.640486.AE, 2270968, 18310262.
4. Janssens HJ, Janssen M, van de Lisdonk EH, van Riel PL, van Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet 2008, 371:1854-1860. 10.1016/S0140-6736(08)60799-0, 18514729.
5. Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz HH. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. J Antimicrob Chemother 2007, 60:638-644. 10.1093/jac/dkm254, 17626023.
6. Becker A, Leonhardt C, Kochen MM, Keller S, Wegscheider K, Baum E, et al. Effects of two guideline implementation strategies on patient outcomes in primary care: a cluster randomized controlled trial. Spine 2008, 33:473-480. 10.1097/BRS.0b013e3181657e0d, 18317189.
7. Peters-Klimm F, Muller-Tasch T, Remppis A, Szecsenyi J, Schellberg D. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice-results from a cluster-randomized controlled trial of implementation of a clinical practice guideline. J Eval Clin Pract 2008, 14:823-829. 10.1111/j.1365-2753.2008.01060.x, 19018915.
8. Bleidorn J, Gágyor I, Kochen MM, Wegscheider K, Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?- results of a randomized controlled pilot trial. BMC Med 2010, 8:30. 10.1186/1741-7015-8-30, 2890534, 20504298.
9. ICH Good Clinical Practice Guideline 2011, Last access Jan 21, ICH Good Clinical Practice Guideline., http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf.
10. Heidenreich R, Himmel W, Böckmann H, Hummers-Pradier E, Kochen MM, et al. Documentation of electronic patient records (EPRS) in German general practices: a telephone survey. Z Arztl Fortbild Qualitatssich 2005, 99:573-580. (German).
11. McNulty CA, Richards J, Livermore DM, Little P, Charlett A, Freeman E, et al. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother 2006, 58:1000-1008. 10.1093/jac/dkl368, 16998209.
12. Bower P, Wilson S, Mathers N. Short report: how often do UK primary care trials face recruitment delays?. Fam Pract 2007, 24:601-603. 10.1093/fampra/cmm051, 17872907.
13. Bell-Syer SE, Thorpe LN, Thomas K, Macpherson H. GP Participation and Recruitment of Patients to RCTs: Lessons from Trials of Acupuncture and Exercise for Low Back Pain in Primary Care. Evid Based Complement Alternat Med 2008.
14. McKinstry B, Hammersley V, Daly F, Sullivan F. Recruitment and retention in a multicentre randomised controlled trial in Bell's palsy: a case study. BMC Med Res Methodol 2007, 7:15. 10.1186/1471-2288-7-15, 1847527, 17391510.
15. van der Wouden JC, Blankenstein AH, Huibers MJ, van der Windt DA, Stalman WA, Verhagen AP. Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research. J Clin Epidemiol 2007, 60:819-824. 10.1016/j.jclinepi.2006.11.010, 17606178.
16. Brosteanu O, Houben P, Ihrig K, Ohmann C, Paulus U, Pfistner B, Schwarz G, Strenge-Hesse A, Zettelmeyer U. Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials. Clin Trials 2009, 6:585-596. 10.1177/1740774509347398, 19897532.
17. Sensible guidelines for the conduct of clinical trials 2011, last access Jan 21, Sensible guidelines for the conduct of clinical trials., http://www.ctsu.ox.ac.uk/projects/sg.
18. Clinical trials transformation initiative 2011, last access Jan 21, Clinical trials transformation initiative., https://www.trialstransformation.org/.
19. Wise J. Strengthen clinical trials driven by investigators, Europe research councils say. BMJ 2009, 338:b1111. 10.1136/bmj.b1111, 19293229.
20. Stewart PM, Stears A, Tomlinson JW, Brown MJ. Regulation--the real threat to clinical research. BMJ 2008, 337:a1732. 10.1136/bmj.a1732, 18927171.
21. Duley L, Antman K, Arena J, Avezum A, Blumenthal M, Bosch J, et al. Specific barriers to the conduct of randomized trials. Clin Trials 2008, 5:40-48. 10.1177/1740774507087704, 18283079.
22. Yusuf S. Damage to important clinical trials by over-regulation. Clin Trials 2010, 7:622-625. 10.1177/1740774510387850, 21138920.
23. Yusuf S, Bosch J, Devereaux PJ, Collins R, Baigent C, Granger C, et al. Sensible guidelines for the conduct of large randomized trials. Clin Trials 2008, 5:38-39. 10.1177/1740774507088099, 18283078.
24. McMahon AD, Conway DI, Macdonald TM, McInnes GT. The unintended consequences of clinical trials regulations. PLoS Med 2009, 3:e1000131. 10.1371/journal.pmed.1000131, 2768793, 19918557.
25. Hummers-Pradier E, Beyer M, Chevallier P, Eilat-Tsanani S, Lionis C, Peremans L, et al. Series: The research agenda for general practice/family medicine and primary health care in Europe. Part 4. Results: specific problem solving skills. Eur J Gen Pract 2010, 16:174-181. 10.3109/13814788.2010.504982, 20825274.
26. VanLare JM, Conway PH, Sox HC. Five next steps for a new national program for comparative-effectiveness research. N Engl J Med 2010, 362:970-973. 10.1056/NEJMp1000096, 20164480.